Everything is Bigger in Texas...Including Medicaid

Medicaid enrollment has climbed by 80,000 in Texas despite the state opting out of Medicaid expansion.

Jul 20, 2014 at 1:00PM

Despite choosing not to embrace Medicaid expansion, more than 80,000 Texans have enrolled in the government program thanks to increased awareness following the launch of Obamacare exchanges launch last fall.

The jump in enrollment presents a problem for states like Texas that opted against bumping up eligibility because it increases the amount the state will spend on the program, but it's good news for Centene (NYSE:CNC) and Molina (NYSE:MOH), two companies that help run the state's Medicaid program.


Source: Governor of Texas Flickr

First, a bit of background
Initially, the Affordable Care Act's Medicaid expansion provision effectively increased eligibility to 138% of the Federal poverty level nationwide, or roughly $33,000 for a family of four. For those that were found newly eligible, the Federal government agreed to pay 100% of the cost of care initially and no less than 90% of costs in the future, with the states picking up the rest.

However, the Supreme Court gave states the option not to expand their program in 2012 and as a result; just 26 states opted to increase coverage.

Even though a significant number of states didn't expand (including Texas), Medicaid has still proven widely successful at signing up new members nationwide.

According to the Centers for Medicare and Medicaid Services, more than 6 million people have enrolled in Medicaid since last summer, including 725,000 members in non-expansion states like Texas. That means that private Medicaid insurers that are running plans in states that didn't expand Medicaid are still getting a windfall.


Source: Centene Corp.

Surging demand
Centene's biggest markets opted out of Medicaid expansion, including Texas, where Centene serves 900,000 members and Florida, where Centene serves 230,000 members.

But even though so much of Centene's business comes from these non-expansion states, Centene revenue is jumping.

The company serves nearly 2.9 million people who participate in government funded programs like Medicaid and CHIP, and a 13% jump in membership in the first quarter resulted in Centene's sales growing by a third to $3.46 billion in the first quarter.

Molina Healthcare's Medicaid business is humming too. Molina serves 2.1 million members including 246,000 in Texas, but it's less reliant on non-expansion states for growth. That's because Molina does a lot of business in California, a state that embraced expansion and has seen Medicaid applications soar.

In the first quarter, California accounted for 47,000 of Molina's 133,000 new Medicaid members and those new members helped Molina's revenue climb 21% to $2.1 billion.

Although Medicaid insurers like Centene and Molina have smaller margins than larger, more diversified insurers that serve commercial customers, rising revenue has both companies expecting to post significant earnings growth this year. Centene expects its EPS will reach between $3.60 and $3.90 this year, up from $2.87 last year, and Molina is guiding investors to expect EPS of between $4 and $4.50 this year, up from $3.13 in 2013.

Fool-worthy final thoughts
Kaiser estimates that as many as one million Medicaid applications nationwide have yet to be processed, so there's likely to be additional membership growth in the third quarter too.

But growth over the coming year won't just come from expansion states. Kaiser reports that roughly 875,000 Texans qualify for Medicaid but haven't yet signed up for the program.

Centene will release its second quarter results on July 22nd and Molina will update investors with its second quarter numbers on July 30th, so investors won't have to wait long to find out whether rising membership drove profits again last quarter, but given the numbers we're seeing out of states like Texas, it wouldn't surprise me if both companies posted solid results.

Leaked: This coming blockbuster will revolutionize health care way beyond Texas
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Todd Campbell owns shares of Molina Healthcare and Centene Corp. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers